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Abstract: Herpes simplex virus 1 (HSV-1) can infect a wide range of cell types, including cells of the
adaptive and innate immunity but, normally, it completes a fully-permissive replication cycle only
in epithelial or neural cells. Complex mechanisms controlling this delicate balance in immune cells
and consequent restriction of HSV-1 infection in these cells have not been completely elucidated.
We have recently demonstrated that the transcription factor nuclear factor kappa B (NF-κB) can
act as a main permissiveness regulator of HSV-1 infection in monocytic cells, however, mediators
involved in this regulation have not been identified. To better define mechanisms involved in this
phenomenon and, particularly, the possible involvement of ROS, wild type U937 cells or U937 cells
stably transfected with a dominant-negative (DN) IκB-mutant and selenium-containing compounds,
as anti-oxidants, were utilized. The main results can be summarized as follows. HSV-1 infection
induces an immediate ROS production in U937 monocytic cells that can efficiently activate NF-κB but
not in DN-IκB-mutant cells. Treatment with selenium-containing antioxidants efficiently inhibited
HSV-1-induced ROS generation while producing increased levels of HSV-1 replication and a reduction
of HSV-1-induced NF-κB activation in U937 monocytic cells. Our results suggest a scenario in which
an efficient NF-κB-dependent ROS production in response to infection could contribute in limiting
HSV-1 replication in monocytes/macrophages, thus avoiding possible irreparable damage to the
innate immune system of the host during HSV-1 infection.
Keywords: HSV-1; oxidative stress; NF-κB; innate response
1. Introduction
Herpes simplex virus 1 (HSV-1) has coexisted with modern humans since the beginning of their
appearance on Earth. In fact, HSV-1 co-diverged from its ancestor virus concurrently with modern
humans from primates [1]. Such a long-term co-evolution has resulted in a balanced and complex
mechanism of persistent infection, characterized by latency and reactivation, which is suitable for, under
normal conditions, the survival of both the human host and the virus [2]. Persistent infection by HSV-1
and its closely related herpes simplex virus 2 (HSV-2) in healthy individuals is ensured by a number of
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regulated interactions among elements of the host response and of the evasion strategies of the virus.
Nevertheless, a dysregulation of these interactions could transform a mild and often asymptomatic
viral infection into a dramatic and life-threatening disease such as encephalitis, as also highlighted
by murine experimental models [3,4]. Interestingly, studies by different authors have highlighted a
number of complex interactions among HSV-1 or HSV-2 herpes simplex viruses (HSV) and components
of the innate antiviral response, such as regulated cell death and the transcription factor nuclear factor
kappa B (NF-κB) [5–15]. One peculiarity of the regulated virus/cell interactions occurring during
infections by HSV is that they greatly differ according to the type of infected cell. The three main,
different types of relationships that HSV establish with infected cells can be principally distinguished
as lytic infection, typical of epithelial cells, latent infection, typical of neurons, and low-productive or
non-productive infection, which is typical of mononuclear cells of the adaptive or innate immunity. The
low or non-productive infection [16,17] is the less studied and characterized form of HSV infection and
can evolve differently according to the specific cell type and its differentiation stage. Particularly, HSV
infection of monocytes/macrophages is generally characterized by the fact that HSV can efficiently enter
target cells and initiate the replication cycle. Then, the replication cycle is immediately interrupted
(non-productive or abortive infection) or, at least, partially restricted, originating a low-productive, but
still well-detectable, semi-permissive replication cycle [18]. Recently, we demonstrated that activation
of NF-κB during HSV-1 infection, differently from what occurs in fully permissive cells where it has
been hijacked to a pro-virus factor, plays a central role in restriction of infection in monocytic cells,
preserving these cells from both viral replication and apoptosis [19]. In fact, viral production, as
assayed by different techniques, as well as levels of apoptotic regulated cell death, that proved to be
quite low in spite of high-dose virus challenge in wild type U937 cells, were dramatically increased in
U937 cells in which NF-κB activation was stably inhibited by a dominant-negative IκBα, with respect
to control U937 cells [19]. Intriguingly, however, none of the investigated NF-κB-dependent genes,
most commonly associated with the antiviral response, seemed to be involved in restriction of HSV-1
infection in monocytic cells and underlying mechanisms have not yet been completely elucidated [19].
Emerging data indicate that production of reactive oxygen species (ROS) plays beneficial effects in
several biological functions, including innate immunity and antiviral responses. It has long been known
that ROS act as a microbicidal compound produced by NADPH oxidases (NOXs) in phagosomes of
phagocytic cell types [20]. Moreover, ROS have been shown to regulate a number of processes involved
in the innate response, such as expression of innate-response-related genes, signal transduction,
inflammasome activation, autophagy and programmed necrosis [21,22]. However, the role of ROS
production during viral infections is still controversial. In fact, a lot of data have been accumulated
over the past years showing that treatment with anti-oxidants could be beneficial against infections
caused by different viruses. Actually, results reported in different studies indicate that in the case of
HSV-1 infection, ROS production could exert an antiviral effect [23–26]. Interestingly, overexpression
of IκBα has been demonstrated to inhibit inducible ROS production, showing also that this presumable
component of the innate response could be under the control of NF-κB. However, the contribution of a
possible crosstalk between NF-κB signalling and ROS production in innate immune response to HSV-1
infection in monocytic cells remains largely elusive.
The present study was aimed to further elucidate the relationships among ROS production, NF-κB
activation and viral replication in monocytic cells infected by HSV-1. For this purpose, we used
U937 monocytic cells in which NF-κB activation was functional or, in parallel, ablated by expression
of a dominant-negative IκBα. Moreover, to inhibit ROS production, we used selenium-containing
compounds whose anti-oxidant and biological properties have been previously described [27].
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2. Materials and Methods
2.1. Cells
Human monocytic wild type U937 cells, originally obtained from the Istituto Zooprofilattico,
Brescia, Italy, and U937 cells in which NF-κB activation was abrogated by expression of a dominant
negative form of murine IκBα (DN-IκB) to produce stable transfectants, were grown and cultured
as previously described [28], and checked by EMSA for inhibition of NF-κB activation. HEp-2 and
THP-1 cells, originally obtained from American Type Culture Collection (ATCC), were cultured in
RPMI 1640 (Lonza, Basel, Switzerland) supplemented with 10% fetal bovine serum (FBS, Euroclone,
Milan, Italy). All media were supplemented with 100 units/mL penicillin, 100 mg/mL streptomycin
and 2 mM L-glutamine (Lonza). Medium for THP-1 cells was also supplemented with 1 mM sodium
pyruvate, 10 mM Hepes and 4.5 g l-1 glucose (final concentration). Cell lines were cultured at 37 ◦C in
a 5% CO2 incubator.
2.2. Antibodies and Reagents
Mouse monoclonal antibodies against HSV-1 gD DL6 (sc-21719) and HSV-1 ICP0 (sc-53070) were
obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA); mouse anti-human β-actin (mAbcam
8226) from Abcam (Cambridge, UK). The secondary fluorescein isothiocyanate (FITC)-conjugated
and horseradish peroxidase (HRP)-conjugated anti mouse IgG antibodies were obtained from EMD
Millipore (Temecula, CA, USA).
Se-(Methyl)selenocysteine hydrochloride (SeMC, M6680), the oxidant-sensitive dye
2′,7′-dichlorofluorescin diacetate (DCFH-DA, D6883), H2O2 (H1009) and cycloheximide (CHX, 01810)
were purchased from Sigma-Aldrich (St. Louis, MO, USA). A second selenium-based compound used
in this study and identified as Seleno-Diamino Acid 4 (SeDA4), is a synthetic molecule obtained and
characterized for its anti-oxidant and biological properties as previously described [27].
2.3. Virus, Infections and Treatments
HSV-1 virus strain F, originally obtained from ATCC, was propagated, quantified and stored as
described below. Briefly, to obtain virus stocks, sub-confluent monolayers of Vero cells were inoculated
with HSV-1 F at a multiplicity of infection (MOI) of 0.01 for 2 h at 37 ◦C in DMEM supplemented with
1% FBS. Virus inoculum was then removed, fresh DMEM supplemented with 5% FBS was added,
and the cells were incubated at 37 ◦C in 5% CO2. When a cytopathic effect of 100% was ascertained,
additional FBS was added (20% final concentration) and infected cultures were frozen and thawed
three times. Cell debris was then removed by centrifugation at 2500 RPM for 30 min at 4 ◦C. Virus titers
in clarified supernatants were determined by plaque assay. Virus stocks were kept at −80 ◦C until use.
Monocytic cells and adherent HEp-2 cells were split 24 h before infection and then either mock infected
or exposed to indicated multiplicity of infection (MOI) of HSV-1 for 1 h at 37 ◦C. After the adsorption
period, the virus inoculum was replaced with RPMI 1640 containing 1% FBS and cultures were further
incubated at 37 ◦C for 8, 16 or 20 h post infection (p.i.). For short-time kinetics experiments, some
samples were collected during the adsorption period. In these cases, the time from initial contact with
virus has been reported as time of exposure to HSV-1.
For modulation of ROS production, cells were pre-incubated with 20 µM of selenium-based
compounds for 48 h, 5 µM of H2O2 for 0.5 h, or with vehicle alone as a control for 48 h or 0.5 h. All
samples were washed three times in complete fresh medium and then infected with HSV-1, as described
above. In some experiments, the combination of ROS-modulating agents and oxidative stress induction
was used. In this case, vehicle- and SeMC- or SeDA4-treated cells were incubated for a further 0.5 h
with H2O2 5 µM or vehicle prior to infection. The time of treatments and the concentrations used were
chosen based on preliminary experiments performed by trypan blue exclusion to select the optimal
experimental conditions, i.e., undoubtedly non-cytotoxic concentration ranges of SeMC, SeDA4 and
H2O2 towards U937 and HEp-2 cells.
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For inhibition of de novo protein synthesis, U937 cells were pretreated with 1% FBS phenol-red-free
RPMI containing CHX (1 µg/mL), or equal volumes of DMSO as a control, for 1 h at 37 ◦C. Twenty
minutes before the end of CHX pretreatment, DCFH-DA was added to a final concentration of 10 µM.
After washing, cells were infected with HSV-1 at a MOI 50 for 30 min before microscope analysis.
Concentration of CHX to utilize was selected based on preliminary dose-response experiments that
excluded toxicity and proved efficacy in inhibiting de novo protein synthesis in HSV-1-infected U937
cells for 1 µg/mL CHX at the chosen experimental conditions.
2.4. ROS Detection
Intracellular ROS level was determined using the 2′,7′-dichlorofluorescin diacetate (DCFH-DA),
which is a cell permeable and nonfluorescent agent that can be deacetylated by intracellular esterases
to non-fluorescent DCFH. In the presence of ROS, DCFH is converted intracellularly to the oxidized
fluorescent form, DCF. Cells were shifted to phenol-red-free RPMI with reduced serum (1%) and
preloaded with DCFH-DA 10 µM at 37 ◦C for 30 min before HSV-1 infection. At the designated time
point, cells were washed with PBS and immediately analyzed by Leica DMR fluorescence microscopy
(Leitz, Wetzlar, Germany) or by the Observer Z1 fluorescence microscope (Zeiss, Jena, Germany),
where indicated. For kinetics of virus exposure from 0.5 h to 2 h, cells were incubated with the probe at
the same time, washed and HSV-1-infected or mock-infected with different starting-points to analyze
all samples and relative fluorescent signals simultaneously. For each experiment, as a positive control,
a preload DCFH-DA sample treated with H2O2 10 µM for 0.5 h was added. In preliminary and parallel
experiments, cells were also loaded with the probe at the end of the infection period and imaged
immediately after. No differences in the detectability of the pre- or post-loaded probe for incubation
periods until 4 h were noted but reduced background fluorescence in images taken from preloaded
samples was found.
For quantitative evaluation of ROS positive cells, digital images, collected with brightfield or
FITC filter using 40× or 63× objectives, were analysed by ImageJ algorithm software (NIH, Bethesda,
MD, USA). For each frame, background fluorescence was eliminated and an arbitrary fixed threshold
was set. Resulting green fluorescent positive cells were counted and percentage of DCF fluorescent
cells relative to the total number of cells per frame, obtained in a corresponding acquired brightfield,
was calculated. Data obtained from at least six randomly selected frames from at least two separate
experiments were evaluated per condition. A minimum of 100 cells per frame were analysed. Some
representative images were also taken by a 20× objective.
2.5. Immunofluorescence Microscopy Analysis
For gD detection by immunofluorescence microscopy analysis, experimental cultures were
collected 20 h post infection, and cells were fixed and stained with mouse anti-gD HSV-1 specific
antibody and with Hoechst 33342 as previously described [19]. Adherently growing epithelial HEp-2
cells were cultivated, pre-treated, infected with HSV-1 and processed directly on multi-well slides.
Images were collected using Leica DMR fluorescence microscopy with a 40× objective in a green filter
for FITC-labeled antibody and in a blue filter for Hoechst stained nuclei. For quantification, green
fluorescent gD-positive cells and total blue fluorescent nucleated cells were counted in each captured
field. Amounts of gD positivity were represented as a percentage of positive cells calculated in ten
randomly selected fields from three independent experiments.
2.6. Virus Titer (Plaque Formation) Assay
Virus titer was determined from supernatants of each infected culture by standard plaque assay
on Vero cells as previously described [29]. Results were expressed as the percent yield of HSV-1
with respect to the corresponding control sample (% HSV-1 yield = PFU from infected pre-treated
sample/PFU from infected vehicle-pre-treated sample × 100).
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2.7. Western Blot Analysis
Expression of the immediate-early protein (ICP0) and of a late protein (gD) of HSV-1 in U937
infected and mock-infected samples was evaluated, respectively, at 8 h and 16 h p.i. by western blotting.
Cells were lysed in NP-40 lysis buffer containing protease inhibitors (Roche Applied Science, Penzerberg,
Germany), and the lysates were electrophoresed through denaturing 10% SDS-polyacrylamide gel.
Proteins were transferred onto a nitrocellulose membrane (Bio-Rad, Hercules, CA, USA), followed
by block of non-specific binding with 5% non-fat milk in Tris-buffered saline (TBS) containing Tween
0.1%. Membrane was then incubated with primary antibodies, anti-gD, anti-ICP0 (Santa Cruz) and
anti β-actin (Abcam), and then with HRP-conjugated secondary antibodies, followed by incubation
with Pico-Sensitivity ECL (Thermo Scientific, Waltham, MA, USA). The ImageJ software was utilized
to quantify densitometric values of blots [19].
2.8. NF-kB Binding Assay
For detecting NF-kB activity, nuclear extracts from U937 cells in the different experimental
conditions were assayed by non-radioactive electro mobility shift assay (EMSA). Binding reactions
were performed by incubating 10 µg of nuclear protein extracts and 5 pmol of biotin-labeled kB
DNA probe for 20 min at room temperature [30,31]. Complexes were resolved by non-denaturing
5% polyacrylamide gel electrophoresis and then transferred to a positive charge nylon membrane
(Bio-Rad). Signals from the biotin-labeled probe were detected using LightShift™ Chemiluminescent
EMSA Kit (Pierce, Thermo Fisher Scientific). Densitometric evaluation of scanned films from two
separate experiments by Image J software was performed to quantify NFκB DNA binding activity. Data
were represented as relative density calculated by the ratio between values obtained for all samples
and values of mock vehicle-pre-treated samples.
2.9. Isolation of Total RNA and Real-Time qPCR
The total RNA extraction and real time RT-qPCR analysis procedures were described
previously [19]. Forward (F) and reverse (R) sequences of the primers selected for Nox family
genes by using Primer3 software, are reported in Table 1.
Table 1. Primers utilized for the Nox family genes.
Nox Family
Component Gene Name
GeneBank
Number Sequence (5’→3’)
Nox2/gp91phox CYBB NM_000397 F CTTCCTCAGGGGTTCCAGTG
R GTGAATCGCAGAGTGAAGTGC
Nox4 NOX4 NM_001143837 F TCCAGCCTCCAGAACTTACTTC
R ACCTCTTCTTTGCGTCCACT
p47phox NCF1 NM_000265 F GAGAGCGGTTGGTGGTTCTG
R CACCTGCATAGTTGGGCTCA
2.10. Statistical Analysis
The data were expressed as mean ± standard deviation (SD). For each series of experiments, two
to four independent replicates were performed. Statistical significance was determined by Dunnett’s
multiple comparison test, using Prism 5 (GraphPad Software, San Diego, CA, USA). A p-value < 0.05
was considered to indicate statistical significance.
3. Results
3.1. HSV-1 Infection Induces an Early ROS Production in Monocytic Cells
We have preliminarily checked whether HSV-1 infection resulted in production of ROS in our
experimental model of infection of monocytic cells, consisting of wild type U937 cells. To this purpose
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U937 cells were preloaded with a non-fluorescent agent that could be converted intracellularly to a
fluorescent probe when oxidized by ROS, and then infected by HSV-1 at a MOI of 50 PFU/cell. At
different times, p.i. cells were collected, washed, distributed on multi-well slides and ROS production
was assessed by evaluating the presence of cells harboring the fluorescent probe by fluorescence
microscopy analysis. Results of one representative analysis is reported in Figure 1a. Appearance
of well-detectable fluorescent cells was easily appreciable as early as 30 min p.i. in the HSV-1
infected sample. Fluorescent cells were still well detectable at 1 h p.i., but not at 2 h p.i. Results
can be quantitatively appreciated in Figure 1b, where histograms refer to the mean percentages of
fluorescent cells + S.D., as calculated from three independent experiments, with two fields each.
Preliminary experiments showed that infections with a MOI of 5, 10 or 20 PFU/cell induced lower
levels of ROS-producing cells, which were not significant with respect to control cells at the two lower
concentrations assayed. Results of these experiments clearly confirmed the capacity of HSV-1 to induce
an immediate oxidative stress response, unequivocally disclosed by ROS production, after infection of
monocytic cells. Moreover, these results indicated that the ROS response to infection was transient and
limited to the very early phase of infection.
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(ROS positive cells) from r presentative im ges. 20× objective, scale bar = 50 µm. (B) % of DCF
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three separate experiments (2 frames each). Digital images were captured by 40× or 63× objectives.
* p < 0.001. vs control (h 0).
3.2. HSV-1-Induced ROS Production and Expression of Oxidant Genes Are Dependent on NF-kB Activation in
Monocytic Cells
Results from us and other authors established that NF-κB activation represents a very early event
in the cellular response to HSV-1 infection. In addition, it is known that ROS production could be
affected either positively or negatively by NF-κB activation, depending on implicated variables. Thus,
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we asked whether an interplay could exist among NF-κB activation and ROS production in response
to HSV-1 infection in monocytic cells. We, then, firstly investigated the effects of inhibition of NF-κB
activation on ROS production in U937 cells. To this purpose we took advantage by the availability in
our laboratory of a U937-derived cell line in which NF-κB activation was ablated by stable transfection
with a DN-IκB. Wild type U937 cells and DN-IκB U937 cells were then infected and ROS production
was detected. Results, shown in Figure 2A,B revealed that, surprisingly, ablation of NF-κB activation
completely blocked the ROS-response to HSV-1 infection in monocytic cells at early times tested, while
a quite low percentage of cells in which ROS production could be detected was observed at 2 h p.i. We
asked whether the NF-κB-dependency of the oxidative stress response in U937 cells was limited to
HSV-1 as an inducing agent. To answer this question, we treated wild type and DN-IκB U937 cells
with H2O2. Interestingly, also in this case the oxidative stress was dramatically suppressed in cells in
which NF-κB activation was abrogated.
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Figure 2. Effects of NF-kB ablation on ROS production in U cells. DCFH-DA preloaded U937-DN-IkB
(NFkB DN) were exposed to HSV-1 (MOI = 50 PFU/cell) or vehicle alone (mock) from 0.5 to 2 h for
ROS detection by fluorescence microscopy. In each experiment, DCFH-DA preloaded wt U937 cells
(NFkB wt), exposed or mock exposed to HSV-1 for 0.5 h, were also included as positive controls.
(A) Representative images by 20× objective. Times of HSV-1 exposure (h) are reported in the FITC
frames (0 = mock infected U937-DN-IkB). Scale bar = 50 µm. (B) % of DCF fluorescence positive cells
(mean + S.D.) from 8 frames randomly selected from two independent experiments (4 frames each).
* p < 0.01, ** p < 0.001 vs. control (h = 0). (C) DCFH-DA preloaded NFkB DN or wt U937 cells, were
treated with 5 µM H2O2 for a further 30 min and then washed and analysed for ROS production by
fluorescence microscopy. Objective 40×, scale bar = 50 µm.
ROS production is regulated by specific oxidant genes. We then examined basal levels of
transcriptional activity for three representative genes notoriously involved in the oxidative response,
such as NOX2, NOX4 and p47 in wild type and DN-IκB U937 cells. Figure 3 shows that basal mRNA
levels for NOX2 and p47 were highly reduced in DN-IκB cells with respect to control cells. Basal levels
of NOX4 were not detectable both in control and DN-IκB U937 cells. Taken together, these results
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account for a clear NF-κB-dependency of the ROS response to HSV-1 infection in monocytic cells, thus
revealing a strict interplay among the above mentioned factors.
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Having observed tha HSV-1 infection cause ediate ROS production in U937 monocytic
cells, we asked whether: (i) this effect was restricted to the specific cell line utilized or could be extended
to other monocytic cells, (ii) production of ROS was dependent on de-novo protein synthesis. To answer
the first question, we repeated our experiments of ROS detection in human monocytic THP-1 cells.
Also in this case, cells were preloaded for ROS detection by the fluorescent probe and then infected by
HSV-1 at a MOI of 50 PFU/cell. At different times, p.i. cells were collected, washed, distributed on
multi-well slides and ROS production was assessed as for U937 cells. Results of one representative
analysis is reported in Figure 4a, showing the appearance of well-detectable fluorescent cells as early
as at 30 min p.i. in th HSV-1 infected sample, as occurred for U937 c lls. Results at a l imes ested can
be quantitatively appreciated in Figure 4b, and recapitulate what was observed for U937 cells.
In addition, to verify whether prompt ROS production in response to HSV-1 infection required
protein neosynthesis, U937 cells were infected in the presence of the protein synthesis inhibitor
cycloheximide. Results shown in Figure 5 indicate that no change in ROS-induced fluorescent cells
could be observed following CHX treatment in comparison with control samples, demonstrating
that early ROS production in response to HSV-1 infection of monocytic cells is not dependent on
protein neosynthesis.
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Figure 5. Effects of cycloheximide (CHX) treatment on early ROS induction by HSV-1. U937 cells, 
pretreated with CHX 1 µg/mL or with vehicle alone (Ctr) for 1 h, were loaded with DCFH-DA before 
exposure to HSV-1 (MOI = 50 PFU/cell) for further 30 min and successive fluorescence microscopy 
analysis. Representative images in bright-field and FITC channel are shown (40× objective, Zeiss 
Observer Z1 microscope). Scale bar Scale bar = 10 µm. 
3.4. Selenium-Based Compounds Inhibit ROS Production in Monocytic Cells Infected by HSV-1 
The following question was to ascertain whether the HSV-1-induced ROS production in 
monocytic cells could be affected by compounds endowed with anti-oxidant activities. To this 
purpose we utilized two members of a family of compounds characterized by the presence of 
selenium in their amino acidic aromatic rings. The biological properties of these compounds, whose 
anti-oxidant activities were already documented, have been previously described [27]. In particular, 
we utilized SeMC, as a reference commercial compound, and SeDA4, as a newly in-house synthesized 
compound. U937 cells were pretreated at non-toxic concentrations of SeMC and SeDA4 before 
loading with the revealing probe, infection with HSV-1 and successive detection of ROS. As shown 
in Figure 6, pretreatment with the selenium-based compounds greatly suppressed the ROS 
production induced by HSV-1 infection in U937 cells. 
Figure 5. Effects of cycloheximide (CHX) treat early ROS induction by HSV-1. U937 cells,
pretreated with CHX 1 µg/mL or with vehicle alon for 1 h, were loa ed with DCFH-DA before
exposure to HSV-1 (MOI = 50 PFU/cell) for further 30 in and successive fluorescence microscopy
analysis. Representative images in bright-field and FITC channel are shown (40× objective, Zeiss
Observer Z1 microscope). Scale bar Scale bar = 10 µm.
3.4. Selenium-Based Compounds Inhibit ROS Production in onocytic Cells Infected by HSV-1
The following question was to ascertain whether the HSV-1-induced ROS production in monocytic
cells could be affected by compounds endowed with anti-oxidant activities. To this purpose we utilized
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two members of a family of compounds characterized by the presence of selenium in their amino
acidic aromatic rings. The biological properties of these compounds, whose anti-oxidant activities
were already documented, have been previously described [27]. In particular, we utilized SeMC, as a
reference commercial compound, and SeDA4, as a newly in-house synthesized compound. U937 cells
were pretreated at non-toxic concentrations of SeMC and SeDA4 before loading with the revealing
probe, infection with HSV-1 and successive detection of ROS. As shown in Figure 6, pretreatment with
the selenium-based compounds greatly suppressed the ROS production induced by HSV-1 infection in
U937 cells.Viruses 2019, 11, x FOR PEER REVIEW 11 of 19 
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scale bar = 50 µm. (B) % of DCF fluorescence positive cells (mean + S.D) from 6 frames randomly 
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including: western blot analysis of the immediate early ICP0 viral protein at 8 h p.i. (Figure 7A), 
western blot analysis of the late gD viral protein at 16 h p.i. (Figure 7B), detection of the gD protein 
by fluorescence microscopy at 20 h p.i. (Figure 5C), and detection of virus yield from infected cultures 
(Figure 7D). Results obtained using the four different methods coherently demonstrated that pre-
treatment with the SeDA4 and SeMC unequivocally facilitated the progression of infection. This 
result revealed that ROS production during the early phases of HSV-1 infection exerted an inhibitory 
effect towards viral replication. Interestingly, this effect was well detectable even for the immediate 
early ICP0 protein synthesis, as early as at 8 h p.i. Moreover, when the oxidative stress was super-
induced by addition of H2O2 30 min before infection, viral replication was reduced, with respect to 
control infected cells, as shown by all the four assays performed (Figure 7A–D). However, both 
Figure 6. Effects of seleniu - antioxidants on early ROS induction by HSV-1. U937 cells
were incubated with SeDA4 (20 µM), SeMC (20 µM) or vehicle alone for 48 h and then preloaded
with F -DA before exposure to HSV-1 (MOI = 50 PFU/cell) for a further 30 min and successive
fluorescence microscopy analysis. (A) Representative images in bright-field (upper panels) and FITC
(bottom panels) of cells subjected to different experimental conditions are displayed. Objective 20×,
scale bar = 50 µm. (B) % of DCF fluorescence positive cells (mean + S.D.) from 6 frames randomly
selected from two independent experiments (3 frames each). * p < 0.001 vs. control HSV-1-infected
cells (vehicle).
3.5. Inhibition of ROS Production Promotes Viral Replication in HSV-1 Infected Monocytic Cells in a
NF-κB-Dependent Manner
We then wanted to investigate whether the interplay among ROS production and NF-κB activation
could affect HSV-1 infection in monocytic cells. To this purpose, we monitored the progression of HSV-1
replication in control and DN-IκB U937 cells, pretreated or not with the selenium-based antioxidants.
Figure 7 reports results obtained in wild type, NF-κB activation-competent, U937 cells. The progression
of HSV-1 replication was monitored by several techniques, including: western blot analysis of the
immediate early ICP0 viral protein at 8 h .i. (Figure 7A), western blot analysis of the late gD viral
protein at 16 h p.i. (Figure 7B), detection of the gD protein by fluorescence microscopy at 20 h p.i.
(Figure 5C), and detection of virus yield from infected cultures (Figure 7D). Results obtained using
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the four different methods coherently demonstrated that pre-treatment with the SeDA4 and SeMC
unequivocally facilitated the progression of infection. This result revealed that ROS production during
the early phases of HSV-1 infection exerted an inhibitory effect towards viral replication. Interestingly,
this effect was well detectable even for the immediate early ICP0 protein synthesis, as early as at
8 h p.i. Moreover, when the oxidative stress was super-induced by addition of H2O2 30 min before
infection, viral replication was reduced, with respect to control infected cells, as shown by all the four
assays performed (Figure 7A–D). However, both SeDA4 and SeMC actually retained their capacity to
promote viral replication even after oxidative stress super-induction by H2O2, in the two assays in
which they were tested (Figure 7C,D). Conversely, when the effects of the selenium-based compounds
where assayed in DN-IκB U937 cells infected by HSV-1, i.e., in cells in which HSV-1-induced ROS
production was inhibited by ablation of NF-κB activation, no changes in ROS production (Figure 8A,B),
as well as in viral replication, as detected by fluorescence microscopy analysis of gD positive cells
(Figure 8C), were observed. The latter results demonstrated that the selenium-amino acids, at the
utilized concentrations, did not exert by themselves any promoting or inhibiting effect on HSV-1
replication in monocytic cells.
3.6. Pre-Treatment with Selenium-Based Antioxidants Inhibits NF-κB Activation in Monocytic Cells Infected
by HSV-1
HSV-1 has been previously demonstrated to trigger NF-κB activation by a signaling pathway
involving oxidative stress in macrophages [32]. We then asked whether such a phenomenon could
occur even in our experimental model of HSV-1 infection, characterized by the NF-κB-dependency
of ROS production. To this purpose, we assayed levels of NF-κB activation by EMSA in U937 cells
pretreated or not with SeDA4 or SeMC and successively infected by HSV-1. Figure 9 shows that
the selenium-based antioxidants actually exerted an inhibitory effect towards HSV-1-induced NF-kB
activation, indicating a strict relationship between the phenomenon of inhibition of ROS production
and that of inhibition of NF-kB activation induced by SeDA4 and SeMC in HSV-1-infected cells.
3.7. HSV-1-Induced ROS Production and Related Effects Are Monocytic Cell Type-Dependent
Having demonstrated a noticeable, complex interplay among NF-κB activation, ROS production
and HSV-1 replication in monocytic cells, we were interested in establishing whether the observed
phenomena could be restricted to cells of the specific, monocytic cell type utilized in our experiments,
which are not fully permissive to HSV-1. ROS generation and effects of selenium-based compounds on
viral replication were then assayed in the fully permissive HEp-2 epithelial cell line infected by HSV-1.
Figure 10 shows that neither ROS production in response to infection (Figure 10A) nor any change in
viral replication after SeMC treatment, as detected by gD expression (Figure 10B), could be detected in
HEp-2 cells infected by HSV-1. Moreover, unresponsiveness of HEp-2 cells to produce ROS following
HSV-1 infection was not caused by a lack in the oxidative machinery, as shown by a well detectable
oxidative response to H2O2 super-induction (Figure 10A). Finally, differently from what occurred
in monocytic cells, no effects of SeMC on viral replication, even after H2O2 super-induction, were
observed in HEp-2 cells (Figure 10B). All together, these results account for a cell type-dependency of
the interplay between NF-κB activation and ROS production in HSV-1 infected cells.
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30 min before infection with HSV-1 (MOI 50 PFU/cell). At the indicated times, cells (hpi) were 
collected and assayed for virus replication by different techniques. (A,B) Western blot analysis of 
ICPO (A) and gD (B) viral proteins from samples pre-incubated with antioxidants or complete media 
(vehicle) before exposure to H2O2 and infection. Mock-infected cultures were also included. Top 
panels: densitometric analysis normalized to β-actin expression and expressed as mean + S.D of data 
obtained from two evaluations in duplicates. Bottom panels: representative gels. (C) 
Immunofluorescence microscopy analysis of gD expressing cells from samples pre-incubated with 
antioxidants or complete medium (vehicle) before exposure to H2O2 and infection. Analysis by IFA is 
expressed as % positive cells (mean + S.D.) calculated from 20 different fields per conditions of four 
Figure 7. Effects of ROS-modulating agents o - replication. U937 cells wer pre-incubated with
selenium-based antioxidants (SeDA4 or Se ) for 48 h and/or exposed to H2O2 for a further
30 min before infection with HSV-1 (MOI 50 PFU/cell). At the indicated times, c lls (hpi) were collected
and assayed for virus replication by different techniques. (A,B) Western blot analysis of ICPO (A) and
gD (B) viral proteins from samples pre-incubated with antioxidants or complete media (vehicle) before
exposure to H2O2 and infection. Mock-infected cultures were also included. Top panels: densitometric
analysis normalized to β-actin expression and expressed as mean + S.D. of data obtained from two
evaluations in duplicates. Bottom panels: representative gels. (C) Immunofluorescence microscopy
analysis of gD expressing cells from samples pre-incubated with antioxidants or complete medium
(vehicle) before exposure to H2O2 and infection. Analysis by IFA is expressed as % positive cells
(mean + S.D.) calculated from 20 different fields per conditions of four separate experiments (5 fields
each). (D) Virus yield in supernatants determined by plaque assay in samples obtained from the same
experiments of C. Data are expressed as percentage of HSV-1 yield with respect to infected, untreated
cells (vehicle). * p < 0.05, ** p < 0.001, *** p < 0.0001 versus HSV-1-vehicle treated groups (only infected
groups are represented).
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by EMSA. (A) EMSA gel from one representative experiment. The position of NF-kB DNA shift is 
indicated. (B) Quantitative evaluation of EMSA by densitometry image analysis. Results are 
expressed as fold change in shift band intensities from all sample versus corresponding mock-
infected, vehicle treated samples. Each bar represents the mean value + S.D. of three independent 
experiments. * P < 0.001 vs mock-infected, vehicle treated samples. 
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Figure 9. Eff cts o selenium-based antioxidants on HSV-1-induced NF-kB activation. Nuclear extracts
from U937 cells treated with S DA4 (20 µM), SeMC (20 µM) or vehicle alone for 48 h and then exposed
or mock-exposed to HSV-1 MOI 50 for further 1 h, were prepared for NF-kB DNA activity by EMSA.
(A) EMSA gel from one representative experiment. The position of NF-kB DNA shift is indicated.
(B) Quantitative evaluation of EMSA by densitometry image analysis. Results are expressed as fold
change in shift band intensities from all sample versus corresponding mock-infected, vehicle treated
samples. Each bar represents the mean value + S.D. of three independent experiments. * p < 0.001 vs
mock-infected, vehicle treated samples.
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expressing cells by immunofluorescence microscopy analysis of cells cultured with vehicle or SeMC 
(20 µM) for 48 h and then treated or not with H2O2 (5 µM) for 30 min before infection with HSV-1 
(MOI = 0.5 PFU/cell). Cells were collected at 20 h post infection. Analysis by IFA is expressed as % 
positive cells (mean + S.D.) calculated from 10 different fields per conditions of two independent 
experiments. No statistically significant differences were found between different conditions.  
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the cross-talk between NF-κΒ activation and oxidative stress in the framework of mechanisms that 
underlie the restriction of HSV-1 infection in monocytic cells. Actually, it is rather obvious that 
restriction of HSV infection in monocytes/macrophages plays a pivotal role in preventing the 
catastrophic scenario of massive destruction by HSV once in contact with this component of the 
innate immune defence. Nevertheless, although HSV infection of mononuclear 
monocytic/phagocytic cells has been described by years, few data are available on complex 
mechanisms underlying the full or partial restrictiveness of HSV infection in these cells [10,18,37,38]. 
In fact, results we obtained provide some simple, but solid, novel findings that could contribute in 
Figure 10. ROS modulation in HEp-2 cells infected by HSV-1. (A) Fluorescence microscopic analysis of
cells preloaded with DCFH-DA before exposure to HSV-1 (MOI = 10 PFU/cell) for 2 h or treat ent with
5 µM of H2O2 for 30 min. Object ve: 40×. Scale bar = 50 µm. (B) Evaluation of gD-HSV-1 expressing
cells by immunofluorescence microscopy analysis of cells cultured with vehicle or SeMC (20 µM)
for 48 h and then treated or not with H2O2 (5 µM) for 30 min before infection with HSV-1 (MOI =
0.5 PFU/cell). Cells were collected at 20 h post infection. Analysis by IFA is expressed as % positive
cells (mean + S.D.) calculated from 10 different fields per conditions of two independent experiments.
No statistically significant differences were found between different conditions.
4. Discussion
Existence of a complex, not univocal, interplay between NF-κB activation and oxidative stress, and
awareness that this interplay could impact on the innate response, have been known for years [33–36].
Moreover, evidence for such an interplay in response to HSV-1 infection of macrophages has been
already given [32]. In the present study, however, we addressed for the first time the issue of the
cross-talk between NF-κB activation and oxidative stress in the framework of mechanisms that underlie
the restricti of HS -1 infection in monocytic cells. Actua ly, it is rather obvious that restriction of
HSV infection in monocytes/macrophages plays a pivotal role in preventing the catastrophic sc nario
of massive destruction by HSV once in contact with this component of the innate i mune defence.
Nevertheless, although HSV infection of mononuclear monocytic/phagocytic cells has been described
by years, few data are available on complex mechanisms underlying the full or partial restrictiveness
of HSV infection in these cells [10,18,37,38]. In fact, results we obtained provide some simple, but solid,
novel findings that could contribute in understanding as to why the progression of HSV-1 infection is
so different in fully permissive epithelial cells and not in fully permissive monocytic cells.
A novel finding from our study is that the immediate oxidative stress response to HSV-1 in
monocytic cells is NF-κB-dependent. Even if, based on the results obtained by other authors in
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different, not virus-related, experimental systems, this is not fully surprising, it is the first time that
this is demonstrated for ROS-induction by HSV-1. However, we must consider that our observation
is strictly related to the monocytic cell type and cannot be generalized to all types of HSV infections.
Interestingly, in fact, we detected a similar, prompt oxidative burst in response to HSV-1 infection in
the two monocytic cell lines examined, but not in epithelial fully permissive HEp-2 cells in which,
notoriously, NF-κB activation is equally induced by the virus [5]. Nevertheless, considering the pivotal
role of NF-κB activation on restriction of HSV-infection of monocytic cells and that the early activation
of this transcription factor occurs immediately after the first contact of the virus with the HVEM
receptor in cells expressing this receptor, as we demonstrated [31], our novel finding suggests by itself
a possible link between the oxidative stress response and the NF-κB-dependent modulation of HSV-1
infection. Interestingly, moreover, we observed that the state of hypo-responsiveness to oxidative
stress in DN-IκB cells is not restricted to HSV-1-induced triggering but also concerns changes in the
intracellular redox status caused by exposure to non-toxic doses of H2O2. However, further deepening
of this aspect and possible mechanisms involved, is out of the purpose of this study.
A second, well depicted, novel finding we want to highlight is the demonstration that pre-treatment
of monocytic cells with compounds having the capability to inhibit NF-κB-dependent ROS production,
and no direct effect on virus replication as shown by experiments on DN-IκB cells, unequivocally
enhanced viral replication in HSV-1 infected monocytic cells. Sporadic data indicating that an oxidative
stress response could be associated with an antiviral, innate immunity in HSV-1 infected cells have
been previously published [26]. However, these studies were focused on the innate response signalling
cascade and not explicitly on their effects on virus replication. Actually, studies focused on the effects
of antioxidants on HSV viral replication led to the conclusion that inhibition of the oxidative stress
response in HSV infected cells suppressed HSV DNA synthesis, presumably in a NF-κB-dependent
manner [39,40]. These results, apparently, strongly contrast with those reported by us in this study.
However, we must take into consideration that our study and those reported above were carried out
in completely different cellular systems, such as permissive epithelial cells and not fully permissive
monocytic cells, as in our study.
Relevant to this apparent discrepancy between our results and those reported by others, we must
note that previous studies by us and other authors, indicate that NF-κB activation has an enigmatic dual
face in HSV-1 infection. In fact, on one hand, NF-κB activation represents a subtle form of viral immune
evasion that redirects the cellular response to infection to a mechanism for favouring virus replication
in fully permissive cells [11]. Conversely, on the other hand, activation of NF-κB can act as a cellular
antiviral tool to antagonize infection, as shown by existence of specific anti- NF-κB HSV-1 proteins [41]
and by our finding that ablation of NF-κB activation promotes virus replication in monocytic cells [19].
Relevant to the latter is that HSV-1 replication, under normal conditions, progresses in a self-limiting
manner in monocytic cells, as well as in other immune cell types. This consideration prompted us
to hypothesize that the dual role of NF-κB activation towards HSV-1 replication could be related to
the specific cell type in which the virus, once entered, attempts to complete its replication cycle [19].
Unfortunately, the mechanisms capable to explain the differential outcome of NF-κB activation in fully
permissive or not fully permissive cell types were not identified.
Considering that the results reported by us in the present study define a strict interplay between
NF-κB activation and ROS production in monocytic cells infected by HSV-1, we can assume that
the different outcome of antioxidants on HSV-1 replication in epithelial cells and monocytic cells
reflects differences observed on the role of NF-κB activation in cells that are fully permissive to
HSV-1. Further investigation is necessary to confirm this inference and elucidate involved mechanisms.
However, relevant to the above assumption could be our, apparently puzzling, finding that not only
ROS production in response to HSV-1 in monocytic cells is NF-κB dependent, but also that NF-κB
activation induced by HSV-1 is favoured by oxidative stress, as shown in Figure 9. Moreover, our
experiments on CHX-treated cells revealed that the oxidative burst triggered by HSV-1 in monocytic
cells is not dependent on de novo protein synthesis. This suggests the hypothesis that in monocytic cells
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immediately after the first contact with HSV-1 virions, presumably in response to HSV-1 glycoprotein
D/HVEM interaction, an interactive loop involving both NF-κB activation and ROS production is
established and this loop could contribute to determining a status of antiviral innate response that
can limit virus replication in these cells. At the same time, the antioxidant machinery of the cells
should be alerted and activated in order to contain the effects of this loop and to avoid the detrimental
consequences for the cells of an excessive and prolonged oxidative burst. Our results show that
the transient detection of ROS in HSV-1 infected monocytic cells could account for this self-limiting
mechanism. The balance between antiviral factors and proviral immune evasion factors could differ at
the single cell level and this could explain why, in a minority of the monocytic cells, HSV-1 is able in
any case to complete its replication cycle. Moreover, we must consider that the transcription factor
NF-κB exerts a fundamental role also in controlling cell death machinery during infection [19]. As
a consequence, restriction of HSV-1 infection in monocytic cells could be the result of multifactorial
events in which the NF-κB/oxidative stress cross-talk could play a central role. In addition, we cannot
help but notice that our data indicate that a pharmacological inhibition of the oxidative stress could
promote HSV-1 replication in restricted monocytic cells, adding new questions on the use of antioxidant
drugs during HSV-1 infection.
In conclusion, results reported in the present study show that a strict link exists between NF-κB
activation and the oxidative burst in response to HSV-1 infection of monocytic cells. Our results,
although still leaving open questions, depict a novel scenario and offer the basis for further investigation
that could contribute to understanding the mechanisms involved in restriction of HSV-1 infection in
mononuclear immune cells.
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